Barry D Quart Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barry D Quart.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barry D Quart. Barry D Quart is Chief Executive Officer in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and President, CEO and Secretary in Ardea Biosciences, Inc./DE ($IBPI) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Latest Insider Trading Transactions of Barry D Quart
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, HRTX, KNSA, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,646 | 0 | 51,041 | |
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Payment of Exercise | F | 16.66 | 963 | 16,044 | 95,192 | 96.2 K to 95.2 K (-1.00 %) |
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 0.00 | 3,646 | 0 | 96,155 | 92.5 K to 96.2 K (+3.94 %) |
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Gift | G | 0.00 | 600 | 0 | 92,509 | 91.9 K to 92.5 K (+0.65 %) |
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Gift | G | 0.00 | 600 | 0 | 0 | 600 to 0 (-100.00 %) |
| Apr 15 2021 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 0.00 | 600 | 0 | 600 | 0 to 600 |
| Oct 15 2020 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 0.00 | 58,333 | 0 | 58,333 | |
| Oct 15 2020 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 15.72 | 350,000 | 5,502,000 | 350,000 | |
| Oct 15 2020 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 12.12 | 1,158 | 14,036 | 89,226 | 88.1 K to 89.2 K (+1.31 %) |
| Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Quart Barry D | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
| Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 25.02 | 325,000 | 8,131,500 | 325,000 | |
| Oct 04 2019 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | P | 17.50 | 4,571 | 79,993 | 94,652 | 90.1 K to 94.7 K (+5.07 %) |
| Oct 04 2019 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | P | 17.50 | 4,571 | 79,993 | 94,652 | 90.1 K to 94.7 K (+5.07 %) |
| Oct 04 2019 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 18.43 | 806 | 14,853 | 90,081 | 89.3 K to 90.1 K (+0.90 %) |
| Oct 04 2019 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 18.43 | 806 | 14,853 | 90,081 | 89.3 K to 90.1 K (+0.90 %) |
| May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Quart Barry D | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
| Dec 18 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 24.97 | 300,000 | 7,491,000 | 300,000 | |
| Sep 14 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 19,675 | 141,660 | 710,601 | |
| Sep 14 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 19,675 | 141,660 | 89,275 | 69.6 K to 89.3 K (+28.27 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 9.05 | 50,000 | 452,500 | 250,000 | |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 39.05 | 50,000 | 1,952,500 | 69,600 | 119.6 K to 69.6 K (-41.81 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 9.05 | 50,000 | 452,500 | 119,600 | 69.6 K to 119.6 K (+71.84 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 13.22 | 1,607 | 21,241 | 69,600 | 68 K to 69.6 K (+2.36 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 9.05 | 50,000 | 452,500 | 250,000 | |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 39.05 | 50,000 | 1,952,500 | 69,600 | 119.6 K to 69.6 K (-41.81 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 9.05 | 50,000 | 452,500 | 119,600 | 69.6 K to 119.6 K (+71.84 %) |
| Jun 22 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 13.22 | 1,607 | 21,241 | 69,600 | 68 K to 69.6 K (+2.36 %) |
| Mar 19 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 100,000 | 720,000 | 730,276 | |
| Mar 19 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 29.75 | 100,000 | 2,975,000 | 67,993 | 168 K to 68 K (-59.53 %) |
| Mar 19 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 100,000 | 720,000 | 167,993 | 68 K to 168 K (+147.07 %) |
| Mar 16 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 100,000 | 720,000 | 830,276 | |
| Mar 16 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 24.75 | 100,000 | 2,475,000 | 67,993 | 168 K to 68 K (-59.53 %) |
| Mar 16 2018 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 100,000 | 720,000 | 167,993 | 68 K to 168 K (+147.07 %) |
| Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 17.00 | 310,000 | 5,270,000 | 310,000 | |
| Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 12.62 | 1,684 | 21,256 | 67,993 | 66.3 K to 68 K (+2.54 %) |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 13.00 | 310,000 | 4,030,000 | 310,000 | |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 4,630 | 33,336 | 930,277 | |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 4,630 | 33,336 | 66,309 | 61.7 K to 66.3 K (+7.51 %) |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 18.22 | 837 | 15,253 | 61,679 | 60.8 K to 61.7 K (+1.38 %) |
| Mar 03 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 3,472 | 24,998 | 934,907 | |
| Mar 03 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 3,472 | 24,998 | 60,842 | 57.4 K to 60.8 K (+6.05 %) |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 2,315 | 16,668 | 938,379 | |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 2,315 | 16,668 | 82,370 | 80.1 K to 82.4 K (+2.89 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 29.41 | 250,000 | 7,352,500 | 250,000 | |
| Oct 15 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 10,000 | 72,000 | 940,694 | |
| Oct 15 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 10,000 | 72,000 | 80,055 | 70.1 K to 80.1 K (+14.27 %) |
| Sep 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 14,306 | 103,003 | 950,694 | |
| Sep 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 14,306 | 103,003 | 70,055 | 55.7 K to 70.1 K (+25.66 %) |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 10,000 | 72,000 | 965,000 | |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 10,000 | 72,000 | 55,749 | 45.7 K to 55.7 K (+21.86 %) |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 7.60 | 2,881 | 21,896 | 45,749 | 42.9 K to 45.7 K (+6.72 %) |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 40.74 | 3,750 | 152,775 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 40.32 | 5,001 | 201,640 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 23.95 | 1,000 | 23,950 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 23.00 | 8,375 | 192,625 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 20.60 | 1,375 | 28,325 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 11.35 | 1,500 | 17,025 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 10.10 | 1,375 | 13,888 | 0 | |
| Mar 04 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 13.07 | 10,000 | 130,727 | 42,868 | 52.9 K to 42.9 K (-18.92 %) |
| Dec 22 2006 | IBPI | Ardea Biosciences, ... | Quart Barry D | President, CEO and ... | Option Exercise | A | 3.90 | 400,000 | 1,560,000 | 400,000 |
Page: 1